通过NMDAR抗体增强蛋白酶体活性,解释了它们在神经退行性和精神疾病中的治疗作用
Fikret Sahin1, Aslihan Gunel2, Buse Turegun Atasoy3
1Department of Medical Microbiology, Ankara University School of Medicine, Ankara, Turkey. fsahin29@hotmail.com.
Scientific reports
|January 13, 2025
概括
胺酸等NMDAR抗体增加20S蛋白酶的活性,清除与神经退行性疾病和抑郁症相关的有害蛋白质. 这种机制可以解释它们的治疗效果,并提供新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于神经退行性疾病和抑郁症,NMDAR对抗剂 (孟坦丁,胺) 显示出治疗潜力.
- 它们的有效性背后的确切机制在很大程度上是未知的.
- 由20S蛋白质酶维持的蛋白质平衡是关键的,并且随着年龄的增长而下降,导致疾病.
研究的目的:
- 研究NMDAR抗体在神经保护和抑郁症中的分子机制.
- 探索20S蛋白酶体途径在调解这些药物的作用中的作用.
- 在大脑中识别由NMDAR对抗剂调节的特定蛋白标.
主要方法:
- 利用小鼠模型来研究胺管理的影响.
- 使用蛋白质组技术分析了大脑突触蛋白质配置文件.
- 评估了20S蛋白酶体活性对NMDAR抗剂的反应.
- 研究了无素独立的20S蛋白酶体通路 (UIPS).
主要成果:
- NMDAR对抗剂显著增强了20S蛋白酶体的活性.
- 胺素迅速改变了大脑突触蛋白质配置,降低了与阿尔茨海默氏症和帕金森病相关的蛋白质.
- 受影响的蛋白质被丰富了与可塑性和内分泌大麻素信号传递相关的途径.
- 有证据表明,涉及到无素独立的20S蛋白酶体通路 (UIPS).
结论:
- 通过UIPS,NMDAR对抗剂通过增强20S蛋白酶体活性来促进细胞蛋白质平衡.
- 这一作用可能是它们在神经退行性疾病和抑郁症中的治疗益处的基础.
- 研究结果表明,针对蛋白质聚合和细胞功能障碍的新疗法有可能出现.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Antiepileptic Drugs: Glutamate Antagonists
276
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
276
Antidepressant Drugs: MAOIs and Other Agents
188
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
188
Parkinson's Disease: Treatment
206
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
206
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K


